Show summary Hide summary
- Why Australian regulators acted on vitamin B6 safety
- How vitamin B6 works and where it comes from
- Health risks linked to too much vitamin B6
- What the TGA will require starting June 2027
- Why the specific dose cutoffs matter
- How limits compare around the world
- Practical steps for consumers using B6 supplements
- Evidence and patient reports that informed the decision
Australia has moved to curb the easy sale of high-dose vitamin B6 supplements after a safety review revealed cases of serious nerve damage and other harms tied to prolonged use. Regulators say many people get enough B6 from food, and the new rules aim to prevent accidental overdoses from multiple products.
Why Australian regulators acted on vitamin B6 safety
The Therapeutic Goods Administration (TGA) reviewed reports, studies and public submissions. Many complaints described long-lasting harm after taking supplements with large amounts of vitamin B6.
Eggs every day for months: simple check reveals shocking blood test result
Popular childhood food ingredient may raise adult anxiety: study
Regulators concluded that rising supplement use has increased the risk of toxicity. The TGA found evidence linking supplements to peripheral nerve injury in some users.
How vitamin B6 works and where it comes from
Pyridoxine, commonly called vitamin B6, supports hundreds of biochemical tasks.
- It helps brain development and immune responses.
- It assists metabolism of proteins, fats and carbohydrates.
- Dietary sources include poultry, fish, eggs, starchy vegetables and fortified cereals.
Most people meet needs through food. Daily recommended intakes are small, commonly around 1.3–1.7 mg for adults, depending on age and sex.
Health risks linked to too much vitamin B6
Vitamin B6 toxicity is rare from food. It is mainly seen in people taking high-dose supplements over time.
Common signs and complications
- Peripheral neuropathy: numbness, tingling, pain and weakness in hands and feet.
- Reduced ability to feel heat, cold or pain.
- Gastrointestinal upset and skin changes.
- Heightened sun sensitivity and skin lesions in some cases.
Clinicians warn that symptoms can persist even after stopping supplements. That makes it hard for patients to connect their problems to a vitamin.
What the TGA will require starting June 2027
The regulator announced stepped controls based on the amount of B6 per recommended daily dose.
- Products with up to 50 mg per day remain available over the counter.
- Products providing 50–200 mg per day will require pharmacist supervision at purchase.
- Products above 200 mg per day will need a prescription.
- Manufacturers must display clear front-of-pack warnings when a product contains vitamin B6.
These thresholds reflect concerns about dose-related nerve injury and aim to reduce inadvertent high intake.
Why the specific dose cutoffs matter
Experts note the exact toxic dose varies across individuals. Some studies report neuropathy at doses under 500 mg daily, and rarely below 200 mg daily.
To reduce risk, the TGA placed controls where the evidence suggests harm becomes more probable. The move targets products that could deliver repeated, high doses.
How limits compare around the world
Countries set different upper limits for vitamin B6.
- United States: an adult upper limit is often cited at 100 mg per day.
- European Food Safety Authority: tolerable upper intake level set at 12 mg per day for adults.
- Japan: limits vary by age and sex, roughly 40–60 mg per day.
These variations reflect different interpretations of the data and safety margins used by authorities.
Practical steps for consumers using B6 supplements
- Check labels for the amount of vitamin B6 per dose.
- Consider multivitamins or B-complex products that deliver less than 10 mg daily.
- Avoid stacking multiple products that each contain B6.
- Talk with a pharmacist or health professional before starting high-dose regimens.
- If you have tingling or numbness, stop supplements and seek medical advice.
Pharmacists can help review total daily intake from all sources, including fortified foods and energy drinks.
Evidence and patient reports that informed the decision
The TGA reviewed more than 100 public submissions describing “severe, sometimes permanent” effects. Researchers and clinicians also provided data on dose-related neuropathy.
Those real-world reports were a key driver of the new sales and labeling requirements. Regulators said they want clearer warnings so users do not unknowingly reach toxic levels.
